Tutkimusapuraha
Täältä voit lukea lisää tutkimuksista, joihin olemme osallistuneet ja joita olemme rahoittaneet vuosien varrella. Löydät eri määrärahat valikosta.
Säätiö tukee alueensa eturintamassa olevaa tutkimusta. Tutkimushankkeet, joille myönnetään tutkimusapurahaa, valitaan neuvoa-antavasta komiteassa. Miten prosessi menee, voit lukea lisää Täältä.
Haluatko tukea tutkimusta?
Tukemalla meitä autat diabeteksen torjunnassa. Tukeasi tarvitaan, jotta voimme tukea diabetestutkimuksia, joilla uskomme olevan parhaat edellytykset saada aikaan parempia hoitomuotoja sekä tyypin 1 että tyypin 2 diabetekseen. Perimmäinen tavoitteemme on löytää parannuskeino diabetekseen, mutta myös lisätä tietoutta sairaudesta ja sen komplikaatioista.
2024
Professor Kirsi Laitinen, University of Turku
20 000 EUR
Impact of gestational diabetes mellitus on child gut microbiota and neurocognitive development.
Dr Sami Jalil, University of Helsinki
20 000 EUR
Genome Editing in Human Stem Cell-Derived Islets: A Novel Strategy for Treating Monogenic Diabetes.
Dr Inna Starskaia, University of Turku
20 000 EUR
In-depth analysis of immune response to identify changes associated with progression and endotypes of type 1 diabetes.
Dr Kedar Batkulwar, University of Turku
20 000 EUR
Importance of a novel miRNA in the development and early prediction of type 1 diabetes.
Dr Krishna Adeshara, University of Helsinki
10 000 EUR
Unraveling the genetic and epigenetic landscape of advanced glycation end products: a potential link to cardiovascular disease in adults with type 1 diabetes.
Dr Diego Balboa, University of Helsinki
10 000 EUR
Engineered enveloped particles for genome editing of stem cell derived pancreatic islets in vitro.
Diana Toivola, Åbo Akademi University
10 000 EUR
Beta-cell cytoskeletal keratin 18 and its type 1 diabetes associated variant (SNP) in beta-cell function and stress protection.
Dr Tero Jarvinen, Tampere University
10 000 EUR
Accelerated diabetic wound healing by a wound homing peptide.
Dr Amirbabak Sioofy Khojine, Tampere University
10 000 EUR
Efficacy of antiviral therapy: aiming at type 1 diabetes.
2023
Dr Niina Matikainen, Helsinki University
10 000 EUR
Contribution of postprandial triglyceride-rich lipoproteins to the increased residual CVD risk during statin treatment in Type 2 Diabetes
Dr Kaisa Ivaska, University of Turku
10 000 EUR
Bone marrow adiposity in the pathophysiology of Type 2 Diabetes
Dr Constanze Schmot, Helsinki University
10 000 EUR
Targeting fluid flow shear stress-induced cell injury in diabetic kidney disease
Dr Rim Bouslama Helsinki University
10 000 EUR
Unravelling a new tie between inflammation and diabetic kidney disease
Ms Inna Starskaia, University of Turku
10 000 EUR
Early immune response in children en route to type 1 diabetes to provide insights into the heterogeneity of the disease
2021
2020
Dr Olof Eriksson, Uppsala University
10 000 EUR
GPR44 as a PET marker for measuring beta cell mass in human
Professor Anders Tengholm, Uppsala University
10 000 EUR
Rap and Ras signalling in insulin secretion
2019
Professor Vesa Olkkonen, University of Helsinki
40 000 EUR
Delineating novel mechanisms of human adipocyte lipid metabolism in typs 2 diabetes and insulin resistance;miR-221-3p as a bait
2018
2017
2016
Mr Nagendra Yaluri, University of Eastern Finland
6 000 EUR
Diabetogenic effects of statins
Dr Jonna Saarimaki-Vire, University of Helsinki
10 000 EUR
Importance of cell-cell interactions and heterogeneity in human pluripotent stem cell-derived islet-like clusters to model diabetes
Mr Shalem Raju Modi, University of Eastern Finland
6 000 EUR
Novel treatments for type 2 diabetes via SIRT1 activation and regulation of insulin sensitivity in muscle and adipose tissues
Dr Aila Ahola, Folkhalsan Institute of Genetics
10 000 EUR
The association between self-management of type 1 diabetes and diabetic complications – Finnish Diabetic Nephropathy (FinnDiane) Study
Dr Riikka Kivela, University of Helsinki
10 000 EUR
Transcription factor Prox1 – a potent regulator of glucose metabolism?
Miss Maria Vahatupa, University of Tampere
10 000 EUR
Vascular homing peptide CAR in pathological retinal angiogenesis and CAR-decorin in ocular fibrosis in mouse
2015
Tero Jarvinen Medical School, University of Tampere
10 000 EUR
Enhanced wound healing in diabetes by wound homing, cell penetrating peptide induced syndecan-4 dependent cell migration
Sanna Lehtonen, University of Helsinki
10 000 EUR
Identification of small molecules that enhance beta cell proliferation and differentiation
Diego Balboa, University of Helsinki
10 000 EUR
In vitro maturation of stem cell derived pancreatic beta cells for diabetes research grant
Maarit Lehti, LIKES Foundation, Jyvaskyla
10 000 EUR
Significance of HDL-C on energy metabolism in type 2 diabetes
Essi Havula, University of Helsinki
10 000 EUR
Transcriptional control of dietary sugar metabolism and homeostasis
2014
Dr Satu Pekkala, University of Turku
10 000 EUR
Development of Novel Treatment Strategies for Type 2 Diabetes and non-Alcoholic Fatty Liver Disease based on gut microbiota
Dr Tiinamaija Tuomi, University of Helsinki
10 000 EUR
FINNMODY - Monogenic diabetes in Finland
Dr Arno Hänninen, University of Turku
10 000 EUR
The role of gut microbiota and Akkermansia muciniphila in protection against autoimmune (type 1) diabetes
2013
PhD Diana Toivola, Åbo Akademi Turku
5 000 EUR
Keratin intermediate filament as regulators in the endocrine pancreas
M.Sc. Ph.D researcher Niyas K Saleem, Itä-Suomen Yliopisto
5 000 EUR
MicroRNAs are as Emerging Biomarkers for Type 2 Diabetes and Metabolic Syndrome
M.D. PhD Hänninen, Arno Lauri Mikael, Turun Yliopisto
5 000 EUR
Probiotic bacteria in the prevention of type 1 diabetes in the NOD mouse
Amirbabak Sioofy-Khojine, Tammerfors Universitet
5000 EUR
Bidrag för att kunna jobba med Malin Flodström Tullberg vid Karolinska Institutet
2012
Havula Essi, filosofian maisteri, Helsingin University
5 000 EUR
Genetic mechanisms in cellular sugar sensing and metabolism
Hakkola Jukka, professori, Oulun University
5 000 EUR
Metformiinin molekyylivaikutukset maksassa
Putaala Jukka, lääketieteen tohtori, Helsingin University
5 000 EUR
Subclinical risk factors for cerebrovascular disease in patients with T1D: A longitudinal long-term follow-up study
Toivola Diana, professori, Åbo Akademi Turku
5 000 EUR
The role of keratin intermediate filaments for the function of pancreatic islets and type I diabetes